Phase 1 1 trial
Phase 1
NCT05965102 Aug 2023 → Apr 2025 non-small cell lung carcinoma Second Affiliated Hospital of Guangzhou Medical University
Unknown
No outcome recorded
Phase 1/2 1 trial
Phase 1/2
NCT06682780 Sep 2025 → Dec 2028 expected neoplasm LaNova Medicines Limited
Recruiting
No outcome recorded
Phase 2 18 trials · 1 met primary
Phase 2
NCT06766578 Dec 2024 → Dec 2027 expected adenocarcinoma Shandong Provincial Hospital
Recruiting
No outcome recorded
Phase 2
NCT06211114 Feb 2024 → Feb 2026 overdue collecting duct carcinoma Peking University Cancer Hospital & Institute
Recruiting
No outcome recorded
Phase 2
NCT06125080 Oct 2023 → Oct 2025 overdue triple-negative breast carcinoma Huihua Xiong
Recruiting
No outcome recorded
Phase 2
NCT05892237 Jul 2023 → Feb 2025 non-small cell lung carcinoma Dong Wang
Unknown
No outcome recorded
Phase 2
NCT05981157 Jun 2023 → Dec 2025 nasopharyngeal carcinoma Zhongshan People's Hospital, Guangdong, China
Unknown
No outcome recorded
Phase 2
NCT05941338 Mar 2023 → Feb 2025 overdue head and neck squamous cell carcinoma , oral cavity cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Recruiting
No outcome recorded
Phase 2
NCT05638984 Jan → Dec 2023 —
Fudan University
Unknown
No outcome recorded
Phase 2
NCT06122493 Nov 2022 → Nov 2026 expected esophageal squamous cell carcinoma Ruijin Hospital
Recruiting
No outcome recorded
Phase 2
NCT05380271 Jul → Dec 2022 non-small cell lung carcinoma Gang Wu
Unknown
No outcome recorded
Phase 2
NCT05392686 Jun 2022 lung cancer Tianjin Medical University Cancer Institute and Hospital
Unknown
No outcome recorded
Phase 2
NCT05303038 May 2022 → Apr 2024 —
Fudan University
Unknown
No outcome recorded
Phase 2
NCT05528367 Jan 2022 → Jun 2024 gastric cancer Zhejiang Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT05092217 Oct 2021 → Oct 2023 nasopharyngeal carcinoma Eye & ENT Hospital of Fudan University
Unknown
Met primary
Phase 2
NCT05050630 Aug 2021 → Jul 2022 aggressive B-cell non-Hodgkin lymphoma , large B-cell lymphoma Affiliated Hospital to Academy of Military Medical Sciences
Unknown
No outcome recorded
Phase 2
NCT04969029 Jun 2021 → Dec 2023 colon carcinoma Tianjin Medical University Cancer Institute and Hospital
Unknown
No outcome recorded
Phase 2
NCT04860674 May 2021 → Apr 2024 B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma Zhejiang Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT04770207 Nov 2020 → Nov 2029 expected hepatocellular carcinoma Second Affiliated Hospital of Guangzhou Medical University
Recruiting
No outcome recorded
Phase 2
NCT05520814 Aug 2018 → Dec 2023 nasopharyngeal carcinoma Sichuan Cancer Hospital and Research Institute
Unknown
No outcome recorded
Show 8 more trials Phase 4 1 trial
Phase 4
NCT06311916 May 2024 → Dec 2027 expected hepatocellular carcinoma Chen Xiaoping
Not yet recruiting
No outcome recorded
Comparator or background therapy 2 trials
Phase 2
NCT05448781 Background Jul 2022 → Jul 2023 non-small cell lung carcinoma Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Unknown
No outcome recorded
— NCT07062484 Comparator Jul → Dec 2025 overdue nasopharyngeal carcinoma Sichuan Cancer Hospital and Research Institute
Not yet recruiting
No outcome recorded